• 1. Examination of the hydrogen-bonding networks in small water clusters (n = 2–5, 13, 17) using absolutely localized molecular orbital energy decomposition analysis?
  Erika A. Cobar,Paul R. Horn,Robert G. Bergman,Martin Head-Gordon Phys. Chem. Chem. Phys., 2012,14, 15328-15339
• 2. Emerging investigator series: bacteriophages as nano engineering tools for quality monitoring and pathogen detection in water and wastewater
  Fereshteh Bayat Environ. Sci.: Nano, 2021,8, 367-389
• 3. Fast-Track to Research Data Management in Experimental Material Science-Setting the Ground for Research Group Level Materials Digitalization.
  LarsBanko,AlfredLudwig
• 4. Excitable dynamics in the bromate–sulfite–ferrocyanide reaction
  J. Zagora,M. Vosla?,L. Schreiberová,I. Schreiber Phys. Chem. Chem. Phys., 2002,4, 1284-1291
• 5. Fate of nitrogen-15 in the subsequent growing season of greenhouse tomato plants (Lycopersicon esculentum Mill) as influenced by alternate partial root-zone irrigation
  Maomao Hou,Fenglin Zhong,Qiu Jin,Enjiang Liu,Jie Feng,Tengyun Wang,Yue Gao RSC Adv., 2017,7, 34392-34400

5-Hydroxy-3-(3,4-methylenedioxyphenyl)benzoic acid (CAS No. 1258628-34-0): A Comprehensive Overview

5-Hydroxy-3-(3,4-methylenedioxyphenyl)benzoic acid, identified by its unique CAS No. 1258628-34-0, is a compound of significant interest in the field of pharmaceutical chemistry and biochemistry. This molecule, characterized by its hydroxy and methylenedioxy substituents on a benzoic acid backbone, has garnered attention due to its structural similarity to several naturally occurring phenolic compounds. The presence of these functional groups imparts unique chemical and biological properties, making it a valuable candidate for further investigation in drug discovery and therapeutic applications.

The structure of 5-Hydroxy-3-(3,4-methylenedioxyphenyl)benzoic acid consists of a benzoic acid core substituted at the 3-position with a phenyl ring that carries methylenedioxy groups at the 3 and 4 positions. This arrangement creates a molecule with potential aromatic stacking interactions and hydrogen bonding capabilities, which are critical for its biological activity. The hydroxyl group at the 5-position further enhances its reactivity and interaction with biological targets.

Recent research has highlighted the pharmacological potential of compounds with a similar structural motif. Studies have demonstrated that derivatives of this class exhibit various biological activities, including anti-inflammatory, antioxidant, and anticancer properties. The methylenedioxyphenyl moiety, in particular, is known for its role in enhancing the bioavailability and metabolic stability of pharmaceutical compounds. This feature makes 5-Hydroxy-3-(3,4-methylenedioxyphenyl)benzoic acid a promising scaffold for developing novel therapeutic agents.

In the context of drug development, the hydroxyl group on the benzoic acid ring provides a site for further functionalization, allowing chemists to tailor the molecule's properties for specific applications. For instance, modifications at this position can influence solubility, metabolic pathways, and target binding affinity. The methylenedioxyphenyl group also offers opportunities for structural diversity, enabling the exploration of different pharmacophores within this chemical family.

One of the most compelling aspects of 5-Hydroxy-3-(3,4-methylenedioxyphenyl)benzoic acid is its potential role in neuroprotective therapies. Emerging research suggests that compounds with this structural framework may interact with neurotransmitter systems and mitigate oxidative stress, which are key pathological mechanisms in neurodegenerative diseases. The hydroxyl and methylenedioxy groups contribute to its ability to scavenge free radicals and modulate inflammatory responses, making it a candidate for treating conditions such as Alzheimer's disease and Parkinson's disease.

Additionally, studies have explored the antimicrobial properties of this compound. The aromatic structure and functional groups present in 5-Hydroxy-3-(3,4-methylenedioxyphenyl)benzoic acid allow it to disrupt bacterial cell membranes and inhibit microbial growth. This finding is particularly relevant in light of the growing concern over antibiotic resistance, where novel antimicrobial agents are urgently needed. The compound's ability to interact with bacterial enzymes and cellular components makes it a promising candidate for further development as an antimicrobial agent.

The synthesis of 5-Hydroxy-3-(3,4-methylenedioxyphenyl)benzoic acid involves multi-step organic reactions that require careful optimization to ensure high yield and purity. Common synthetic routes include Friedel-Crafts acylation followed by hydrolysis and selective reduction steps. Advances in synthetic methodologies have enabled more efficient production processes, making it feasible to scale up synthesis for research and commercial purposes.

In conclusion,5-Hydroxy-3-(3,4-methylenedioxyphenyl)benzoic acid (CAS No. 1258628-34-0) represents a fascinating compound with diverse biological activities and therapeutic potential. Its unique structural features make it an attractive scaffold for drug discovery efforts aimed at developing novel treatments for various diseases. As research continues to uncover new applications for this molecule,5-Hydroxy-3-(3,4-methylenedioxyphenyl)benzoic acid is poised to play an important role in future medical advancements.

• 24351-56-2(3',4'-(Methylenedioxy)-3-biphenylcarboxylic Acid)
• 526-34-1(7-methoxy-1,3-dioxaindane-5-carboxylic acid)
• 1261960-47-7(5-Methoxy-3-(3,4-methylenedioxyphenyl)benzoic acid)
• 61440-96-8(Benzoic acid, 2-[6-(hydroxymethyl)-1,3-benzodioxol-5-yl]-)
• 24351-54-0(2-Biphenyl-1,3Dioxol-5-Yl-Carboxylic Acid)
• 482627-94-1(7-hydroxy-1,3-benzodioxole-5-carboxylic acid)
• 94-53-1(Piperonylic acid)
• 61440-99-1(1,3-Benzodioxole-5-carboxylic acid, 6-[2-(hydroxymethyl)phenyl]-)
• 193151-97-2(4-Biphenyl-1,3Dioxol-5-Yl-Carboxylic Acid)
• 56359-06-9(1,3-Benzodioxole-5-carboxylic acid, sodium salt (1:1))